Panel Clinical Strategy track
Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region
Tue, Nov 10, 2026 · 1:00–1:55 PM CET Clinical Strategy Stage, Koelnmesse
About this session
Examine cost-benefit frameworks for bridging studies across Japan, Korea, Taiwan and ASEAN countries, balancing regulatory requirements, ethnic sensitivity considerations and commercial ROI to accelerate regional approvals Explore the unique regulatory pathways and requirements across key Asian markets, including PMDA (Japan), MFDS (Korea), TFDA (Taiwan) and emerging frameworks in Southeast Asian nations Discuss proven strategies for managing multi-country trials in the region, including site selection and engagement in mature and emerging markets, patient recruitment in heterogeneous…
Speaker
-
Head of Clinical Operations & Regulatory Affairs · Graythan Regulatory Services
Panelist